Acquired by CalciMedica in May 2023
GRAY - Graybug Vision, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Redwood City,
United States
Type: Equity
GRAY price evolution
GRAY
| (in millions $) | 31 Jan 2023 | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $17.3 | $10.17 | $13.87 | $8.36 |
| Short term investments | $21.82 | $33.46 | $36.82 | $46.92 |
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $39.67 | $45.07 | $51.73 | $58.22 |
| Long term investments | ||||
| Property, plant & equipment | $0.29 | $2.29 | $2.33 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $0.29 | $2.29 | $2.36 | |
| Total investments | $21.82 | $33.46 | $36.82 | $46.92 |
| Total assets | $39.67 | $45.36 | $54.02 | $60.59 |
| Current liabilities | ||||
| Accounts payable | $1.72 | $0.5 | $1.01 | $0.54 |
| Deferred revenue | ||||
| Short long term debt | $0.2 | $0.3 | $0.4 | $0.39 |
| Total current liabilities | $3.7 | $3.76 | $4.33 | $4.23 |
| Long term debt | $0.1 | |||
| Total noncurrent liabilities | $0.1 | |||
| Total debt | $0.2 | $0.3 | $0.4 | $0.49 |
| Total liabilities | $3.7 | $3.76 | $4.33 | $4.33 |
| Shareholders' equity | ||||
| Retained earnings | -$204.79 | -$197.39 | -$187.58 | -$179.34 |
| Other shareholder equity | -$0.04 | -$0.12 | -$0.18 | -$0.18 |
| Total shareholder equity | $35.97 | $41.6 | $49.69 | $56.26 |
| (in millions $) | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $17.3 | $13.36 | $33.42 | $15.87 |
| Short term investments | $21.82 | $50.31 | $61.62 | $20.09 |
| Net receivables | $0.04 | $0.02 | ||
| Inventory | ||||
| Total current assets | $39.67 | $67.08 | $99.24 | $36.27 |
| Long term investments | ||||
| Property, plant & equipment | $1.98 | $1.95 | $1.98 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $2.01 | $2.55 | $4.39 | |
| Total investments | $21.82 | $50.31 | $61.62 | $20.09 |
| Total assets | $39.67 | $69.09 | $101.79 | $40.66 |
| Current liabilities | ||||
| Accounts payable | $1.72 | $0.53 | $2.51 | $4.64 |
| Deferred revenue | ||||
| Short long term debt | $0.2 | |||
| Total current liabilities | $3.7 | $4.06 | $7 | $12.25 |
| Long term debt | ||||
| Total noncurrent liabilities | $0.01 | $0.01 | $131.36 | |
| Total debt | $0.2 | |||
| Total liabilities | $3.7 | $4.07 | $7.01 | $143.61 |
| Shareholders' equity | ||||
| Retained earnings | -$204.79 | -$169.19 | -$133.37 | -$105.84 |
| Other shareholder equity | -$0.04 | -$0.02 | -$0 | $0 |
| Total shareholder equity | $35.97 | $65.02 | $94.79 | -$102.95 |
| (in millions $) | 31 Dec 2022 | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $0.75 | $3.25 | $4.06 | $6.06 |
| Selling, general & administrative | $6.43 | $4.3 | $4.24 | $4.13 |
| Total operating expenses | $7.71 | $9.98 | $8.3 | $10.18 |
| Operating income | -$7.71 | -$9.98 | -$8.3 | -$10.18 |
| Income from continuing operations | ||||
| EBIT | -$7.4 | -$9.81 | -$8.24 | -$10.15 |
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | -$7.4 | -$9.81 | -$8.24 | -$10.15 |
| Income (for common shares) | -$7.4 | -$9.81 | -$8.24 | -$10.15 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $14.11 | $18.9 | $20.96 | $30.58 |
| Selling, general & administrative | $19.1 | $17.04 | $8.87 | $6.92 |
| Total operating expenses | $36.18 | $35.95 | $29.83 | $37.5 |
| Operating income | -$36.18 | -$35.95 | -$29.83 | -$37.5 |
| Income from continuing operations | ||||
| EBIT | -$35.6 | -$35.82 | -$27.53 | -$37.04 |
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | -$35.6 | -$35.82 | -$27.53 | -$37.04 |
| Income (for common shares) | -$35.6 | -$35.82 | -$34.72 | -$44.09 |
| (in millions $) | 31 Dec 2022 | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 |
|---|---|---|---|---|
| Net income | -$7.4 | -$9.81 | -$8.24 | -$10.15 |
| Operating activities | ||||
| Depreciation | $0.18 | $0.22 | $0.21 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.74 | $1.68 | $1.75 | $1.54 |
| Total cash flows from operations | -$5.07 | -$7.14 | -$4.14 | -$6.52 |
| Investing activities | ||||
| Capital expenditures | $0.35 | -$0.06 | -$0.17 | |
| Investments | $11.91 | $3.51 | $10.11 | $3.24 |
| Total cash flows from investing | $12.26 | $3.46 | $9.72 | $1.52 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$0.05 | -$0.02 | -$0.07 | |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $7.13 | -$3.7 | $5.51 | -$5 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$35.6 | -$35.82 | -$27.53 | -$37.04 |
| Operating activities | ||||
| Depreciation | $0.61 | $0.52 | $0.4 | $0.3 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $6.71 | $5.38 | $1.79 | $0.74 |
| Total cash flows from operations | -$22.88 | -$31.5 | -$32.06 | -$31.21 |
| Investing activities | ||||
| Capital expenditures | $0.12 | -$0.49 | -$1.02 | -$0.6 |
| Investments | $28.78 | $11.24 | -$41.54 | -$20.02 |
| Total cash flows from investing | $26.96 | $10.75 | -$42.56 | -$20.62 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.69 | $96.33 | $0.13 | |
| Net borrowings | ||||
| Total cash flows from financing | -$0.14 | $0.69 | $92.17 | $54.87 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $3.94 | -$20.05 | $17.55 | $3.04 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 21.70M |
| Revenue | $0.00 |
|---|---|
| EBITDA | -$34.99M |
| EBIT | -$35.60M |
| Net Income | -$35.60M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | 1.66 |
| Cash/Share | 0.80 |
| EPS | -$1.64 |
|---|---|
| ROA | -71.34% |
| ROE | -77.61% |
| Debt/Equity | 0.10 |
|---|---|
| Net debt/EBITDA | 0.39 |
| Current ratio | 10.72 |
| Quick ratio | 10.72 |